News

Medicare Crossover Changes and Medicaid Changes

1/24/2011

TO:  All Renal Dialysis Facility Providers

Medicare Crossover Changes:

Effective February 1, 2011, renal dialysis crossover claims will be received from Medicare and will be processed by Medicaid for all renal dialysis providers. 

 

 

*Note:  Crossover claims with Dates of Service prior to January 1, 2011 that crossover from Medicare will not pay correctly.  These crossover claims must be electronically submitted through the previous claim submission process to Medicaid.

 

 

Medicare claims billed by renal dialysis providers will cross over directly from Medicare and will be processed by Medicaid.  Providers are limited to the following codes on Medicare crossover claims.  Future Medicare revisions may require code updates to this table:

 

Revenue Codes

Condition Codes

Procedure Code

Description

821, 881

71, 72,73, 74, 76

 

90999

Hemodialysis, home hemodialysis, self care training, home hemo training and ultrafiltration. 

831, 841, 851

 

74

90945

Dialysis procedure other than hemodialysis

831, 841, 851

 

73

90993

Dialysis training, patient, including helper. 

634,<10,000 635, >or = 10,000

 

Q4081

Injection epogen

636

 

J0882

Darbopoetin alfa, injection

636

 

Appropriate Injectable Codes

Injectable Drugs

250

 

Appropriate NDC Codes (No HCPCS)

PO Drugs

31X, 921

 

Appropriate Lab Codes

Labs

270

 

A4697, A4913 (IV)

Supply/Admin

771

 

Appropriate vaccine HCPCS

Vaccine

 

 

 

Medicaid Changes: 

 

All Medicaid services beginning with dates of service January 1, 2011, and thereafter, must be billed according to the following policy. Medicaid’s new requirements mirror Medicare’s as closely as possible.

 

  Revenue Codes

Condition Codes

Procedure Code

Description

821

71

90999

Hemodialysis, limited to 156 units per year.

831, 841, 851

 

90945

Dialysis procedure other than hemodialysis. 

831, 841, 851

 

73, 74

90993

Dialysis training, patient, including helper.  Limited to 12 per lifetime.

634,<10,000

635, >or = 10,000

 

Q4081*

Injection epogen

636

 

J0882*

Darbopoetin alfa, injection

636

 

Injectable Codes

See Alabama Medicaid Injectable Drug Listing in appendix H for covered injectable drugs. 

 

*EPO and Aranasp Monitoring Policy: 

 

Medicaid is requiring providers include the GS modifier, the ED modifier, or the EE modifiers in mirroring Medicare’s policy, refer to Chapter 8 of the Medicare Claims Processing Manual for further definition.  These modifiers will be considered ‘informational only’ when billed to Medicaid and no reductions in payment will be made for straight Medicaid claims.  Medicaid expects the provider to adhere to the strict definitions defined below:

 

GS

Dosage of EPO or Darbopoetin Alfa has been reduced and maintained in response to hematocrit or hemoglobin level.

ED

The hematocrit level has exceeded 39.0% (or hemoglobin 1evel has exceeded 13.0g/dL) 3 or more consecutive billing cycles immediately prior to and including the current billing cycle

EE

The hematocrit level has exceeded 39.0% (or hemoglobin level has exceeded 13.0g/dL) less than 3 consecutive billing cycles immediately prior to and including the current billing cycle.

 

Providers may contact Jerri Jackson, RN, BSN, at 334-242-5630 or e-mail at jerri.jackson@medicaid.alabama.gov if you have any questions.